Advances in HIV-1 Entry Inhibitors: Strategies to Interfere with Receptor and CoReceptor Engagement

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|12|9|1105-1119

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.9, 2006-03, pp. : 1105-1119

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HIV Co-Receptor CCR5: Structure and Interactions with Inhibitors

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 9, Iss. 3, 2009-06 ,pp. : 279-288

Bentham Science Publishers

Access to resources Recommend Favorite

Chemokine receptor antagonists as HIV entry inhibitors

By  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 2, 2004-02 ,pp. : 251-255

Informa Healthcare

Access to resources Recommend Favorite

Developing clinical role of a CCR5 co-receptor antagonist in HIV-1 infection

By Caldwell David J   Evans Jeffery D  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 18, 2008-12 ,pp. : 3231-3242

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of HIV-1 Entry

By  

Current Pharmaceutical Design, Vol. 19, Iss. 10, 2013-03 ,pp. : 1784-1799

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Progress in the Discovery of New CCR5 and CXCR4 Chemokine Receptor Antagonists as Inhibitors of HIV-1 Entry. Part 2*

By  

Current Medicinal Chemistry - Anti-Infective Agents, Vol. 4, Iss. 2, 2005-04 ,pp. : 133-152

Bentham Science Publishers

Access to resources Recommend Favorite